Anti-obesity Drugs Market Size, Share & Industry Analysis, By Type (Prescription Drugs and OTC Drugs), By Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI104783

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Obesity - By Key Countries/Region
2. New Product Launches
3. Key Industry Developments – Mergers, Acquisition, and Partnerships
4. Pipeline Analysis
5. Impact of COVID-19 on the Global Market
Global Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. India
  2. China
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Novo Nordisk A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. GlaxoSmithKline
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Vivus Pharmaceuticals
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Currax Pharmaceuticals LLC
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Sandoz International GmbH (Novartis AG)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Boehringer Ingelheim International GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Obesity - By Key Countries/Region
2. New Product Launches
3. Key Industry Developments – Mergers, Acquisition, and Partnerships
4. Pipeline Analysis
5. Impact of COVID-19 on the Global Market
Global Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. India
  2. China
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-obesity Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Prescription Drugs
  2. OTC Drug
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail and Online Pharmacy
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Novo Nordisk A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. GlaxoSmithKline
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Vivus Pharmaceuticals
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Currax Pharmaceuticals LLC
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Pfizer Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Sandoz International GmbH (Novartis AG)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Boehringer Ingelheim International GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Anti-obesity Drugs Market Value Share (%), By Type, 2025 & 2034

Figure 02: Global Anti-obesity Drugs Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 03: Global Anti-obesity Drugs Market Value Share (%), By Region, 2025 & 2034

Figure 04: North America Anti-obesity Drugs Market Value (USD billion), by Type, 2025 & 2034

Figure 05: North America Anti-obesity Drugs Market Value Share (%), by Type, 2025

Figure 06: North America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 07: North America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 08: North America Anti-obesity Drugs Market Value (USD billion), by Country, 2025 & 2034

Figure 09: North America Anti-obesity Drugs Market Value Share (%), by Country, 2025

Figure 10: Europe Anti-obesity Drugs Market Value (USD billion), by Type, 2025 & 2034

Figure 11: Europe Anti-obesity Drugs Market Value Share (%), by Type, 2025

Figure 12: Europe Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 13: Europe Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 14: Europe Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 15: Europe Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 16: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Type, 2025 & 2034

Figure 17: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Type, 2025

Figure 18: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 20: Asia Pacific Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 21: Asia Pacific Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 22: Latin America Anti-obesity Drugs Market Value (USD billion), by Type, 2025 & 2034

Figure 23: Latin America Anti-obesity Drugs Market Value Share (%), by Type, 2025

Figure 24: Latin America Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 25: Latin America Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 26: Latin America Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 27: Latin America Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 28: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Type, 2025 & 2034

Figure 29: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Type, 2025

Figure 30: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 31: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 32: Middle East & Africa Anti-obesity Drugs Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 33: Middle East & Africa Anti-obesity Drugs Market Value Share (%), by Country/Sub-region, 2025

Figure 34: Global Anti-obesity Drugs Market Share (%), By Company, 2025

List of Tables

Table 01: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 02: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 03: Global Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Region, 2021–2034

Table 04: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 05: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 06: North America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 07: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 08: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 09: Europe Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 10: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 11: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 12: Asia Pacific Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 13: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 14: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 15: Latin America Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

Table 16: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Type, 2021–2034

Table 17: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 18: Middle East & Africa Anti-obesity Drugs Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 130

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com